Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and prognosis of hypertensive patients hospitalised with COVID-19.

Marcello CovinoGiuseppe De MatteisMaria Livia BurzoMichele SantoroMariella FuorloLuca SabiaClaudio SandroniAntonio GasbarriniFrancesco FranceschiGiovanni Gambassinull null

Published in: Internal medicine journal (2021)

Among hypertensive patients hospitalised for COVID-19, treatment with ACEI or ARB is not associated with an increased risk of in-hospital death.

Keyphrases

hypertensive patients
angiotensin converting enzyme
angiotensin ii
blood pressure
coronavirus disease
sars cov
vascular smooth muscle cells
healthcare
respiratory syndrome coronavirus
emergency department
community acquired pneumonia
acute care
combination therapy